相关实验视频
Updated: May 12, 2026

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
7.9K
针对心血管病理中的线粒体微RNA:精密心脏病学的新前沿
Satinder Kaur1, Gurjit Kaur Bhatti2, Naina Khullar3
1Laboratory of Translational Medicine and Nanotherapeutics, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, India.
Ageing research reviews
|October 18, 2025
概括
线粒体微RNAs (mito-miRs) 是心脏病发作 (心肌梗塞) 的关键调节者. 了解 mito-miRs 为心血管疾病提供了新的治疗点.
科学领域:
- 线粒体生物学 线粒体生物学
- 分子心脏病学分子心脏病学
- 生物医学科学 生物医学科学
背景情况:
- 心血管疾病 (CVD),特别是心肌梗塞 (MI),是全球主要的死亡原因.
- 尽管取得了进展,心肌梗塞仍然无法治愈,这凸显了对新型治疗策略的需求.
- 线粒体在心脏病发病和治疗中至关重要,线粒体的微RNA (mito-miRs) 成为重要的调节者.
研究的目的:
- 探索 mito-miRs 在心血管疾病,特别是心肌梗塞中的作用.
- 阐明 mito-miRs 调节线粒体功能和细胞死亡途径的机制.
- 鉴定 mito-miRs 在治疗心脏病发作中的潜在治疗应用.
主要方法:
- 关于心血管疾病中线粒-miR功能的当前文献的综述.
- 对线粒体新陈代谢,动力学和细胞死亡的线粒体-miR调节的新兴证据的分析.
- 研究米托-米R转位和心脏细胞内的作用.
主要成果:
- 米托-miRs涉及调节线粒体新陈代谢,反应性氧物种 (ROS) 生产,生物能学和生物发生.
- 米托-miRs会影响细胞死亡的过程,包括亡,亡,铁亡和热亡.
- 特定的mito-miRs向关键的心脏细胞类型,如心肌细胞,内皮细胞和纤维细胞.
结论:
- 解读米托-米R机制对于开发针对性miRNA治疗MI的治疗方法至关重要.
- 将米托-miR与干细胞治疗和纳米颗粒输送系统相结合,可能会提高心血管疾病的治疗效率.
相关概念视频
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Mitochondrial Membranes
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
The Inner Mitochondrial Membrane
The inner mitochondrial membrane is the primary site of ATP synthesis. The inner membrane domain that forms a smooth layer adjacent to the outer membrane is called the inner boundary membrane. This domain contains membrane transporters that drive metabolites in and out of the mitochondria. In contrast, the inner membrane network that invaginates into the matrix space is called the cristae membrane. This domain accounts for principle mitochondrial function as it accommodates the protein...
Electron Transport Chain: Complex I and II
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Precursor Proteins
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Most of the mitochondrial precursors...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

